Inactive Instrument
Sector Oramed Pharmaceuticals, Inc. OTC Bulletin Board
Stocks
US68403P1049
Biotechnology & Medical Research
|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 09-21 | Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to S&P Global BMI Index | CI |
| 09-01 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.16% | +3.42% | +8.78% | +34.82% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.16B | |
| -0.37% | -3.81% | -9.09% | -2.21% | +13.34% | +19.75% | +78.12% | +213.91% | +5,294.42% | 57.39B | |
| +1.63% | -1.61% | +1.34% | +0.10% | +6.88% | +3.83% | +36.89% | -17.70% | +210.87% | 47.64B | |
| +0.50% | +2.94% | -1.11% | +9.74% | +160.74% | +344.62% | +722.17% | +640.92% | - | 44.29B | |
| +3.05% | -1.80% | -0.63% | +28.52% | +18.05% | +28.78% | +34.51% | +11.17% | +230.38% | 42.5B | |
| +1.00% | -1.46% | +0.95% | +21.50% | +19.04% | +5.17% | +111.90% | +4.12% | +1,041.57% | 40.71B | |
| -0.54% | +2.41% | -2.92% | -0.54% | +5.93% | +9.31% | +58.85% | +1.88% | +144.91% | 30.97B | |
| +4.42% | +8.04% | +19.22% | +52.91% | +83.84% | +37.62% | +32.27% | -50.00% | - | 28.53B | |
| +0.76% | -1.45% | -5.90% | +0.10% | +2.56% | -7.44% | -11.12% | -60.96% | - | 24.34B | |
| -6.56% | -11.76% | -17.78% | -6.96% | -40.34% | -33.93% | +314.66% | +291.22% | +588.07% | 24.27B | |
| +5.32% | +3.26% | +9.79% | +27.21% | +17.27% | +13.19% | -3.02% | -14.09% | +110.35% | 20.32B | |
| +3.51% | +0.74% | +4.94% | +11.28% | +10.48% | +16.53% | +154.23% | +221.01% | +1,960.81% | 16.73B | |
| +2.15% | +3.03% | -9.16% | -5.37% | +180.86% | +136.14% | +351.43% | +1,738.00% | +664.96% | 15.16B | |
| +0.07% | -0.88% | -15.72% | -16.93% | - | - | - | - | - | 14.96B | |
| +0.91% | -4.04% | +3.88% | +8.91% | +21.06% | +20.10% | +44.77% | -28.86% | +83.57% | 14.63B | |
| +0.79% | +0.82% | -0.27% | +5.37% | +34.27% | +46.79% | +165.81% | +181.44% | +348.55% | 14.47B | |
| +1.45% | +1.06% | -2.53% | -8.69% | +21.88% | -14.87% | +519.17% | - | - | 14.38B | |
| +7.09% | +5.49% | +7.72% | +34.71% | +55.79% | +75.25% | +62.58% | -22.57% | +274.56% | 13.85B | |
| +9.03% | -1.80% | +29.29% | +38.63% | +41.49% | -8.85% | - | - | - | 13.83B | |
| Average | +2.03% | -1.10% | +1.09% | +12.27% | +40.99% | +41.19% | +162.79% | +194.94% | +912.75% | 29.11B | |
| Weighted average by Cap. | +1.80% | -1.01% | +0.86% | +14.12% | +43.52% | +48.90% | +153.67% | +151.05% | +1,299.51% |
- Stock Market
- Stocks
- ORMP Stock
- Stock
- Sector Oramed Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
